Home Newsfeeds First Foundation Files For Mixed-Securities Shelf Offering, Size Not Disclosed

First Foundation Files For Mixed-Securities Shelf Offering, Size Not Disclosed

-Reuters

byMichael Horton

October 12, 2022

1 minute read

-Reuters

Elizabeth Warren Calls For ‘Aggressive Enforcement’ Against ‘Smoke And Mirrors’ Crypto Industry After FTX Fiasco

By Mehab Qureshi

November 10, 12:18 AM

Sen. Elizabeth Warren (D-Mass.) has said the fallout of cryptocurrency exchange FTX (CRYPTO: FTT) shows a dire need for stringent regulations to protect consumers.

$FTT

Credit Suisse Initiates Coverage On Charles River with Outperform Rating, Announces Price Target of $285

By Benzinga Newsdesk

August 25, 5:17 AM

Credit Suisse analyst Katie Tryhane initiates coverage on Charles River (NYSE:CRL) with a Outperform rating and announces Price Target of $285.

CRL

News

U.S. DoT, Pacific Northwest National Laboratory, And Cloudflare Partner To Improve The Cyber Resilience Of The Financial Services Industry By Sharing An Advanced Threat Intelligence Feed

By Benzinga Newsdesk

May 9, 1:32 PM

Cloudflare is powering how the U.S Department of Treasury and PNNL share advanced threat intelligence with the financial sectorCloudflare, Inc. (NYSE:NET), the leading connectivity cloud company, today announced a

NET

Innate Pharma Highlights Early Lacutamab Data In Aggressive Form Of Blood Cancer

By Vandana Singh

December 12, 12:35 PM

Innate Pharma SA (NASDAQ:IPHA) presented data from a preliminary analysis of the TELLOMAK Phase 2 trial demonstrating clinical activity and a…

IPHA

First Foundation Files For Mixed-Securities Shelf Offering, Size Not Disclosed

Related Posts

Elizabeth Warren Calls For ‘Aggressive Enforcement’ Against ‘Smoke And Mirrors’ Crypto Industry After FTX Fiasco

Credit Suisse Initiates Coverage On Charles River with Outperform Rating, Announces Price Target of $285

U.S. DoT, Pacific Northwest National Laboratory, And Cloudflare Partner To Improve The Cyber Resilience Of The Financial Services Industry By Sharing An Advanced Threat Intelligence Feed

Innate Pharma Highlights Early Lacutamab Data In Aggressive Form Of Blood Cancer